RCM Technologies, Inc. Announces Third Quarter Results
| RCM Technologies, Inc. | |||
| Condensed Consolidated Statements of Operations | |||
| (Unaudited) | |||
| (In Thousands, Except Share and Per Share Amounts) | |||
| Thirteen Weeks Ended | |||
| September 27, 2025 | September 28, 2024 | ||
| Revenue | $70,289 | $60,365 | |
| Cost of services | 50,879 | 42,524 | |
| Gross profit | 19,410 | 17,841 | |
| Selling, general and administrative | 14,933 | 13,018 | |
| Depreciation and amortization of property and equipment | 539 | 393 | |
| Amortization of acquired intangible assets | - | 45 | |
| Operating income | 3,938 | 4,385 | |
| Other expense, net | 614 | 619 | |
| Income before income taxes | 3,324 | 3,766 | |
| Income tax expense | 1,065 | 1,020 | |
| Net income | $2,259 | $2,746 | |
| Diluted net earnings per share data | $0.30 | $0.35 | |
| Diluted weighted average shares outstanding | 7,614,695 | 7,789,446 | |
| Thirty-Nine Weeks Ended | |||
| September 27, 2025 | September 28, 2024 | ||
| Revenue | $232,928 | $201,468 | |
| Cost of services | 169,263 | 143,259 | |
| Gross profit | 63,665 | 58,209 | |
| Selling, general and administrative | 45,179 | 40,762 | |
| Depreciation and amortization of property and equipment | 1,364 | 1,012 | |
| Amortization of acquired intangible assets | - | 136 | |
| Potential stock issuance and financial transactions | - | 259 | |
| Operating income | 17,122 | 16,040 | |
| Other expense, net | 2,241 | 1,619 | |
| Income before income taxes | 14,881 | 14,421 | |
| Income tax expense | 4,651 | 3,961 | |
| Net income | $10,230 | $10,460 | |
| Diluted net earnings per share data | $1.34 | $1.31 | |
| Diluted weighted average shares outstanding | 7,656,929 | 7,990,238 | |
RCM Technologies, Inc.
Supplemental Operating Results on a Non-GAAP Basis
(Unaudited)
(In Thousands, Except Per Share Amounts)
The following non-GAAP measures, which adjust for the categories of expenses described below, are non-GAAP financial measures. Our management believes that these non-GAAP financial measures (“Adjusted operating income,”“EBITDA,”“Adjusted EBITDA,”“Adjusted net income” and“Adjusted diluted net earnings per share”) are useful information for investors, shareholders, and other stakeholders of our Company in gauging our results of operations on an ongoing basis and to enhance investors' overall understanding of our current financial performance and period-to-period comparisons. Adjusted operating income, EBITDA, Adjusted EBITDA, Adjusted net income and Adjusted diluted net earnings per share should not be considered alternatives to operating income or net income, as the case may be, as an indicator of performance. In addition, Adjusted operating income, EBITDA, Adjusted EBITDA, Adjusted net income and Adjusted diluted net earnings per share do not take into account changes in certain assets and liabilities and interest and income taxes that can affect cash flows. We do not intend the presentation of these non-GAAP measures to be considered in isolation or as a substitute for results prepared in accordance with GAAP. These non-GAAP measures should be read-only in conjunction with our consolidated financial statements prepared in accordance with GAAP.
The following unaudited table presents the Company's GAAP operating income and GAAP net income and the corresponding adjustments used to calculate Adjusted operating income, EBITDA, Adjusted EBITDA, Adjusted net income and Adjusted diluted net earnings per share for the thirteen and thirty-nine weeks ended September 27, 2025 and September 28, 2024.
| Thirteen Weeks Ended | Thirty-Nine Weeks Ended | ||||||
| September 27, 2025 | September 28, 2024 | September 27, 2025 | September 28, 2024 | ||||
| (Unaudited) | (Unaudited) | (Unaudited) | (Unaudited) | ||||
| GAAP operating income | $3,938 | $4,385 | $17,122 | $16,040 | |||
| Adjustments | |||||||
| Potential stock issuance and financing transactions | - | - | - | 259 | |||
| Equity compensation | 1,033 | 767 | 2,939 | 2,154 | |||
| Adjusted operating income (non-GAAP) | $4,971 | $5,152 | $20,061 | $18,453 | |||
| GAAP net income | $2,259 | $2,746 | $10,230 | $10,460 | |||
| Income tax expense | 1,065 | 1,020 | 4,651 | 3,961 | |||
| Interest expense, net | 584 | 492 | 1,885 | 1,551 | |||
| Depreciation of property and equipment | 539 | 393 | 1,364 | 1,012 | |||
| Amortization of acquired intangible assets | - | 45 | - | 136 | |||
| EBITDA (non-GAAP) | $4,447 | $4,696 | $18,130 | $17,120 | |||
| Adjustments | |||||||
| Potential stock issuance and financing transactions | - | - | - | 259 | |||
| Loss on foreign currency transactions | 30 | 127 | 356 | 68 | |||
| Equity compensation | 1,033 | 767 | 2,939 | 2,154 | |||
| Adjusted EBITDA (non-GAAP) | $5,510 | $5,590 | $21,425 | $19,601 | |||
| RCM Technologies, Inc. | ||||||||
| Supplemental Operating Results on a Non-GAAP Basis (Continued) | ||||||||
| (Unaudited) | ||||||||
| (In Thousands) | ||||||||
| Thirteen Weeks Ended | Thirty-Nine Weeks Ended | |||||||
| September 27, 2025 | September 28, 2024 | September 27, 2025 | September 28, 2024 | |||||
| (Unaudited) | (Unaudited) | (Unaudited) | (Unaudited) | |||||
| GAAP net income | $2,259 | $2,746 | $10,230 | $10,460 | ||||
| Adjustments | ||||||||
| Potential stock issuance and financing transactions | - | - | - | 259 | ||||
| Loss on foreign currency transactions | 30 | 127 | 356 | 68 | ||||
| Equity compensation | 1,033 | 767 | 2,939 | 2,154 | ||||
| Tax impact from normalized rate | (119 | ) | (238 | ) | (257 | ) | (603 | ) |
| Adjusted net income (non-GAAP) | $3,203 | $3,402 | $13,268 | $12,338 | ||||
| GAAP diluted net earnings per share | $0.30 | $0.35 | $1.34 | $1.31 | ||||
| Adjustments | ||||||||
| Potential stock issuance and financing transactions | - | - | - | $0.03 | ||||
| Loss on foreign currency transactions | $0.01 | $0.01 | $0.05 | $0.01 | ||||
| Equity compensation | $0.13 | $0.09 | $0.38 | $0.27 | ||||
| Tax impact from normalized rate | ($0.02 | ) | ) | ) | ) | |||
| Adjusted diluted net earnings per share (non-GAAP) | $0.42 | $0.42 | $1.73 | $1.54 | ||||
| RCM Technologies, Inc. | ||||||||
| Summary of Selected Income Statement Data | ||||||||
| (Unaudited) | ||||||||
| (In Thousands) | ||||||||
| Thirteen Weeks Ended September 27, 2025 | ||||||||
| Specialty Health Care | Engineering | Life Sciences, Data and Solutions | Consolidated | |||||
| Revenue | $30,000 | $31,419 | $8,870 | $70,289 | ||||
| Cost of services | 21,010 | 24,507 | 5,362 | 50,879 | ||||
| Gross profit | 8,990 | 6,912 | 3,508 | 19,410 | ||||
| Gross profit margin | 30.0 | % | 22.0 | % | 39.5 | % | 27.6 | % |
| Thirteen Weeks Ended September 28, 2024 | ||||||||
| Specialty Health Care | Engineering | Life Sciences, Data and Solutions | Consolidated | |||||
| Revenue | $26,554 | $24,167 | $9,644 | $60,365 | ||||
| Cost of services | 18,271 | 18,273 | 5,980 | 42,524 | ||||
| Gross profit | 8,283 | 5,894 | 3,664 | 17,841 | ||||
| Gross profit margin | 31.2 | % | 24.4 | % | 38.0 | % | 29.6 | % |
| Thirty-Nine Weeks Ended September 27, 2025 | ||||||||
| Specialty Health Care | Engineering | Life Sciences, Data and Solutions | Consolidated | |||||
| Revenue | $116,105 | $90,082 | $26,741 | $232,928 | ||||
| Cost of services | 82,634 | 70,496 | 16,133 | 169,263 | ||||
| Gross profit | 33,471 | 19,586 | 10,608 | 63,665 | ||||
| Gross profit margin | 28.8 | % | 21.7 | % | 39.7 | % | 27.3 | % |
| Thirty-Nine Weeks Ended September 28, 2024 | ||||||||
| Specialty Health Care | Engineering | Life Sciences, Data and Solutions | Consolidated | |||||
| Revenue | $101,668 | $70,180 | $29,620 | $201,468 | ||||
| Cost of services | 71,672 | 52,818 | 18,769 | 143,259 | ||||
| Gross profit | 29,996 | 17,362 | 10,851 | 58,209 | ||||
| Gross profit margin | 29.5 | % | 24.7 | % | 36.6 | % | 28.9 | % |
| RCM Technologies, Inc. | ||||
| Condensed Consolidated Balance Sheets | ||||
| (Unaudited) | ||||
| (In Thousands, Except Share Amounts) | ||||
| September 27, | December 28, | |||
| 2025 | 2024 | |||
| (Unaudited) | ||||
| Current assets: | ||||
| Cash and cash equivalents | $1,309 | $4,729 | ||
| Accounts receivable and contract assets, net of provision for credit losses of $1,541 at September 27, 2025 and $1,570 at December 28, 2024 | 83,243 | 77,960 | ||
| Transit accounts receivable | 6,215 | 7,315 | ||
| Prepaid expenses and other current assets | 4,160 | 7,034 | ||
| Total current assets | 94,927 | 97,038 | ||
| Property and equipment, net | 7,624 | 7,368 | ||
| Other assets: | ||||
| Deposits | 278 | 230 | ||
| Deferred tax assets, foreign | 131 | 120 | ||
| Goodwill | 22,147 | 22,147 | ||
| Operating right of use asset | 4,708 | 5,174 | ||
| Total other assets | 27,264 | 27,671 | ||
| Total assets | $129,815 | $132,077 | ||
| Current liabilities: | |||||
| Accounts payable and accrued expenses | $13,080 | $13,369 | |||
| Transit accounts payable | 13,440 | 23,870 | |||
| Accrued payroll and related costs | 12,795 | 9,929 | |||
| Finance lease payable | 889 | 698 | |||
| Income taxes payable | 247 | 346 | |||
| Operating lease liability | 1,121 | 1,046 | |||
| Contingent consideration from acquisitions | 212 | 212 | |||
| Deferred revenue | 6,230 | 4,163 | |||
| Total current liabilities | 48,014 | 53,633 | |||
| Deferred income taxes, net, domestic | 4,526 | 4,526 | |||
| Finance lease payable, net of current position | 566 | 1,112 | |||
| Operating lease liability, net of current position | 3,796 | 4,355 | |||
| Borrowings under line of credit | 31,535 | 34,967 | |||
| Total liabilities | 88,437 | 98,593 | |||
| Contingencies (note 15) | |||||
| Stockholders' equity: | |||||
| Preferred stock, $1.00 par value; 5,000,000 shares authorized; no shares issued or outstanding | - | - | |||
| Common stock, $0.05 par value; 40,000,000 shares authorized; 17,948,409 shares issued and 7,410,510 shares outstanding at September 27, 2025 and 17,838,372 shares issued and 7,602,113 shares outstanding at December 28, 2024 | 898 | 890 | |||
| Additional paid-in capital | 121,453 | 118,845 | |||
| Accumulated other comprehensive loss | (2,757 | ) | (2,920 | ) | |
| Retained earnings (accumulated deficit) | 4,292 | (5,938 | ) | ||
| Treasury stock, 10,537,899 shares at September 27, 2025 and 10,236,259 shares at December 28, 2024 | (82,508 | ) | (77,393 | ) | |
| Total stockholders' equity | 41,378 | 33,484 | |||
| Total liabilities and stockholders' equity | $129,815 | $132,077 | |||
| RCM Technologies, Inc. | |||||
| Condensed Consolidated Statements of Cash Flows | |||||
| (Unaudited) | |||||
| (In Thousands) | |||||
| Thirteen Weeks Ended | |||||
| September 27, 2025 | September 28, 2024 | ||||
| Net income | $2,259 | $2,746 | |||
| Adjustments to reconcile net income to cash used in operating activities | 1,825 | 1,508 | |||
| Changes in operating assets and liabilities: | |||||
| Accounts receivable and contract assets | 515 | (9,033 | ) | ||
| Prepaid expenses and other current assets | (175 | ) | 321 | ||
| Net of transit accounts receivable and payable | (7,659 | ) | 435 | ||
| Accounts payable and accrued expenses | 3,312 | (1,445 | ) | ||
| Accrued payroll and related costs | 2,431 | 1,919 | |||
| Operating lease liabilities | (274 | ) | (228 | ) | |
| Income taxes payable | (538 | ) | 81 | ||
| Deferred revenue | (2,939 | ) | (636 | ) | |
| Deposits | (19 | ) | (12 | ) | |
| Total adjustments | (3,521 | ) | (7,090 | ) | |
| Net cash (used in) operating activities | ($1,262 | ) | ($4,344 | ) | |
| Net cash used in investing activities | (498 | ) | (522 | ) | |
| Net cash (used in) provided by financing activities | (2,379 | ) | 4,375 | ||
| Effect of exchange rate changes on cash and cash equivalents | (24 | ) | 167 | ||
| Decrease in cash and cash equivalents | ($4,163 | ) | ($324 | ) | |
| Thirty-Nine Weeks Ended | |||||
| September 27, 2025 | September 28, 2024 | ||||
| Net income | $10,230 | $10,460 | |||
| Adjustments to reconcile net income to cash used in operating activities | 5,080 | 4,200 | |||
| Changes in operating assets and liabilities: | |||||
| Accounts receivable and contract assets | (5,249 | ) | (5,207 | ) | |
| Prepaid expenses and other current assets | 2,865 | (475 | ) | ||
| Net of transit accounts receivable and payable | (9,330 | ) | (311 | ) | |
| Accounts payable and accrued expenses | (69 | ) | (760 | ) | |
| Accrued payroll and related costs | 2,860 | 433 | |||
| Operating lease liabilities | (809 | ) | (686 | ) | |
| Income taxes payable | (108 | ) | (106 | ) | |
| Deferred revenue | 2,098 | 161 | |||
| Deposits | (48 | ) | 98 | ||
| Total adjustments | (2,710 | ) | (2,653 | ) | |
| Net cash provided by operating activities | $7,520 | $7,807 | |||
| Net cash used in investing activities | (1,398 | ) | (1,589 | ) | |
| Net cash used in financing activities | (9,471 | ) | (9,135 | ) | |
| Effect of exchange rate changes on cash and cash equivalents | (71 | ) | (211 | ) | |
| Decrease in cash and cash equivalents | ($3,420 | ) | ($3,128 | ) | |
| RCM Technologies, Inc. | Tel: 856.356.4500 | Corporate Contacts: |
| 2500 McClellan Avenue | ... | Bradley S. Vizi |
| Pennsauken, NJ 08109 | Executive Chairman | |
| Kevin D. Miller | ||
| Chief Financial Officer |
Legal Disclaimer:
MENAFN provides the
information “as is” without warranty of any kind. We do not accept
any responsibility or liability for the accuracy, content, images,
videos, licenses, completeness, legality, or reliability of the information
contained in this article. If you have any complaints or copyright
issues related to this article, kindly contact the provider above.

Comments
No comment